Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The double face of the same disease.
Di Crescenzo RM, Pagliuca F, Memoli M, Mortaruolo C, Ciancia G, De Renzo A, Mascolo M. Di Crescenzo RM, et al. Among authors: memoli m. J Dtsch Dermatol Ges. 2018 Jul;16(7):932-935. doi: 10.1111/ddg.13522. Epub 2018 May 22. J Dtsch Dermatol Ges. 2018. PMID: 29786950 No abstract available.
Zwei Gesichter derselben Krankheit.
Di Crescenzo RM, Pagliuca F, Memoli M, Mortaruolo C, Ciancia G, De Renzo A, Mascolo M. Di Crescenzo RM, et al. Among authors: memoli m. J Dtsch Dermatol Ges. 2018 Jul;16(7):932-935. doi: 10.1111/ddg.13522_g. J Dtsch Dermatol Ges. 2018. PMID: 29989365 No abstract available.
Thiotepa-busulfan-fludarabine as a conditioning regimen for patients with myelofibrosis undergoing allogeneic hematopoietic transplantation: a single center experience.
Memoli M, Paviglianiti A, Malard F, Battipaglia G, Brissot E, Médiavilla C, Bianchessi A, Banet A, Van de Wyngaert Z, Ledraa T, Belhocine R, Sestili S, Lapusan S, Hirsch P, Favale F, Boussaroque A, Bonnin A, Vekhoff A, Legrand O, Mohty M, Duléry R. Memoli M, et al. Leuk Lymphoma. 2021 Feb;62(2):419-427. doi: 10.1080/10428194.2020.1827246. Epub 2020 Oct 5. Leuk Lymphoma. 2021. PMID: 33012207
Stable pulmonary function after haploidentical stem cell transplantation with post-transplant cyclophosphamide: a single center experience.
Paviglianiti A, Sestili S, Bianchessi A, Memoli M, Dulery R, Banet A, Van De Wyngaert Z, Belhocine R, Ledraa T, Malard F, Mohty M, Brissot E. Paviglianiti A, et al. Among authors: memoli m. Leuk Lymphoma. 2022 Feb;63(2):443-449. doi: 10.1080/10428194.2021.1984460. Epub 2021 Sep 29. Leuk Lymphoma. 2022. PMID: 34587856
Prognostic impact of early minimal residual disease combined with complete molecular evaluation in acute myeloid leukemia with mutated NPM1: a single center study.
Memoli M, Genthon A, Favale F, Lapusan S, Johnson N, Adaeva R, Deswarte C, Battipaglia G, Malard F, Duléry R, Brissot E, Banet A, Van de Wyngaert Z, Mohty M, Delhommeau F, Legrand O, Hirsch P. Memoli M, et al. Leuk Lymphoma. 2022 Sep;63(9):2171-2179. doi: 10.1080/10428194.2022.2064987. Epub 2022 Apr 22. Leuk Lymphoma. 2022. PMID: 35459427
Thiotepa, busulfan and fludarabine conditioning-regimen is a promising approach for older adult patients with acute lymphoblastic leukemia treated with allogeneic stem cell transplantation.
Banet A, Bazarbachi A, Labopin M, Stocker N, Duléry R, Malard F, Van de Wyngaert Z, Genthon A, Memoli M, Legrand O, Bonnin A, Ledraa T, Belhocine R, Sestili S, El-Cheikh J, Mohty M, Brissot E. Banet A, et al. Among authors: memoli m. Bone Marrow Transplant. 2023 Jan;58(1):61-67. doi: 10.1038/s41409-022-01841-0. Epub 2022 Oct 12. Bone Marrow Transplant. 2023. PMID: 36224494
Isocitrate dehydrogenase inhibitors as a bridge to allogeneic stem cell transplant in relapsed or refractory acute myeloid leukaemia.
Genthon A, Dragoi D, Memoli M, Hirsch P, Favale F, Suner L, Chaquin M, Boncoeur P, Marjanovic Z, Bonnin A, Sestili S, Dulery R, Malard F, Brissot E, Banet A, van de Wyngaert Z, Vekhoff A, Delhommeau F, Mohty M, Legrand O. Genthon A, et al. Among authors: memoli m. Br J Haematol. 2022 Aug;198(4):780-784. doi: 10.1111/bjh.18290. Epub 2022 May 26. Br J Haematol. 2022. PMID: 35615877 No abstract available.
Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignancies.
Malard F, Gaugler B, Gozlan J, Bouquet L, Fofana D, Siblany L, Eshagh D, Adotevi O, Laheurte C, Ricard L, Dulery R, Stocker N, van de Wyngaert Z, Genthon A, Banet A, Memoli M, Ikhlef S, Sestilli S, Vekhof A, Brissot E, Marjanovic Z, Chantran Y, Cuervo N, Ballot E, Morand-Joubert L, Mohty M. Malard F, et al. Among authors: memoli m. Blood Cancer J. 2021 Aug 10;11(8):142. doi: 10.1038/s41408-021-00534-z. Blood Cancer J. 2021. PMID: 34376633 Free PMC article.
108 results